Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Jun;33(2):145-9.
doi: 10.1007/s11033-006-6260-x.

Apolipoprotein E gene polymorphism and allele frequencies in the Lebanese population

Affiliations

Apolipoprotein E gene polymorphism and allele frequencies in the Lebanese population

Rami A R Mahfouz et al. Mol Biol Rep. 2006 Jun.

Abstract

Apolipoprotein E (ApoE) genotypes were studied in order to determine the prevalence in the Lebanese population and compare it with other populations. DNA from 160 unrelated healthy donors from our HLA-bank was used. ApoE genotype was determined using the CardioVascular Disease (CVD) StripAssay (this assay is based on a Polymerase Chain Reaction-Reverse Hybridization technique). The prevalence of genotypes E3/3, E3/4, and E2/3 was found to be 69%, 26%, and 22%, respectively, and 0.6% for each of E2/4 and E4/4 genotypes. The Lebanese population tested showed similarities to earlier reported ApoE genotypic distributions (high E3 allele frequency) but also peculiar differences especially to some Arabic countries (total absence of E2 allele among Saudis) and other populations. This is the first report from Lebanon that will serve as a template for future investigations of the prevalence of ApoE alleles in association with various clinical entities.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Zhonghua Yu Fang Yi Xue Za Zhi. 2001 Sep;35(5):297-300 - PubMed
    1. Rheumatology (Oxford). 2004 Dec;43(12):1484-7 - PubMed
    1. Ann Saudi Med. 2004 Sep-Oct;24(5):361-4 - PubMed
    1. Hum Biol. 2000 Dec;72(6):975-81 - PubMed
    1. Breast Cancer Res Treat. 2005 Apr;90(3):257-61 - PubMed

Substances